Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Rueb Yuliya, holds the title of Vice President, Finance (PAO) at Tyra Biosciences, Inc..
On 2026-09-15, the insider transacted 2,925 shares.The shares were transacted at a weighted average price of $9.13 per share, resulting in a total market-relevant value of $27K.
Rueb Yuliya (Vice President, Finance (PAO)) was granted $27K of $TYRA
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.